AMGEN TO PRESENT AT THE GOLDMAN SACHS 14TH ANNUAL HEALTHCARE CEOS UNSCRIPTED CONFERENCE

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference at 1:00 p.m. ET on Thursday Jan. 6, 2022. Robert A. Bradway chairman and chief executive officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen  
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplaces™ by Fortune and Great Place to Work™ and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen .

CONTACT: Amgen, Thousand Oaks
Megan Fox , 805-447-1423 (media)
Trish Rowland , 805-447-5631 (media)
Arvind Sood , 805-447-1060 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-the-goldman-sachs-14th-annual-healthcare-ceos-unscripted-conference-301450042.html

SOURCE Amgen

News Provided by PR Newswire via QuoteMedia

AMGN
The Conversation (0)
bctx stock

BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to welcome the appointment of Jane Gross, Ph.D. to its Board of Directors.

Dr. Jane Gross is a highly experienced biotech executive with over 30 years in leading research and development teams from discovery through preclinical evaluation and clinical development of therapeutics for the treatment of cancer and autoimmune and inflammatory diseases. Dr. Gross currently serves as an Independent Director for aTyr Pharmaceuticals (Nasdaq: LIFE), a biotechnology company developing novel therapeutics for respiratory diseases and multiple cancer indications.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Cizzle Brands Expands its Western Canadian Footprint With All Calgary Co-op and Freson Bros. Stores Now Selling CWENCH Hydration

Cizzle Brands Expands its Western Canadian Footprint With All Calgary Co-op and Freson Bros. Stores Now Selling CWENCH Hydration

As the CWENCH Hydrationâ„¢ brand continues to gain popularity, Cizzle Brands is strategically adding new retailers in select North American markets. Calgary Co-op and Freson Bros. are both chains of supermarkets in Alberta, and are expected to play a key role in building out the presence of CWENCH Hydrationâ„¢ in Western Canada.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announced today the publication of research in the Journal of the American College of Cardiology: Basic to Translational Science ("JACBTS"), titled "Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling" (www.jacc.orgdoiabs10.1016j.jacbts.2024.12.009). This research was conducted by scientists from Tecnológico de Monterrey who, together with researchers from the DeBakey Heart and Vascular Center in Houston, TX, are collaborating with Cardiol on the development of the Company's proprietary subcutaneous ("SubQ") formulation of cannabidiol, CRD-38, to treat heart failure with preserved ejection fraction. This common form of heart failure remains a leading cause of hospitalization worldwide and is associated with a five-year mortality that exceeds 75% in hospitalized patients.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

Canco Petroleum Begins Carrying Cizzle Brands' CWENCH Hydration Beverage in All of its Gas Stations Across Canada

With a strong presence in British Columbia and Alberta and locations in Saskatchewan, Manitoba, New Brunswick, as well as Ontario, the availability of CWENCH Hydrationâ„¢ at all Canco locations enhances the brand's footprint across Canada in the key category of convenience retail.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×